Abstract
The aim was to further characterize the SKG model of rheumatoid arthritis (RA) and its potential for studying intervention treatments, with special focus on bone targeting therapies. Three individual studies were conducted, using a total of 71 SKG mice, comparing arthritis induction with mannan versus zymosan A, female versus male mice, and the effect of dexamethasone intervention treatment initiated at different time points after arthritis induction. Hind paws were embedded undecalcified in methyl methacrylate, and sections were stained with Masson-Goldner trichrome. Areal Bone Mineral Density (aBMD) of the femora was determined with pDXA. RNA was extracted from the hind paws followed by the quantification by reverse transcriptase PCR. SKG mice stimulated with mannan presented a higher arthritis score than mice stimulated with zymosan A. Female SKG mice developed a more severe arthritis than male SKG mice. Dexamethasone inhibited arthritis clinically as well as histologically when the treatment was initiated prophylactically or within the first week of arthritis. Femoral aBMD was lower in animals with arthritis than in control animals. The RANKL RNA expression was elevated in arthritic mice, whereas OPG RNA expression was unchanged. The results suggest mannan as arthritis inductor and female instead of male mice in experiments as well as an optimal time window for the initiation of treatment. Systemic bone loss as well as local up regulation of RANKL was present early in SKG arthritis. These results demonstrate that SKG arthritis is a suitable new model for evaluating therapies in RA.
Similar content being viewed by others
References
Keystone EC, Kavanaugh AF, Sharp JT, Tannenbaum H, Hua Y et al (2004) Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum 50(5):1400–1411
Graudal N, Jurgens G (2010) Similar effects of disease-modifying antirheumatic drugs, glucocorticoids, and biologic agents on radiographic progression in rheumatoid arthritis: meta-analysis of 70 randomized placebo-controlled or drug-controlled studies, including 112 comparisons. Arthritis Rheum 62(10):2852–2863
Asquith DL, Miller AM, McInnes IB, Liew FY (2009) Animal models of rheumatoid arthritis. Eur J Immunol 39(8):2040–2044
Holmdahl R, Jansson L, Larsson E, Rubin K, Klareskog L (1986) Homologous type II collagen induces chronic and progressive arthritis in mice. Arthritis Rheum 29(1):106–113
Sakaguchi N, Takahashi T, Hata H, Nomura T, Tagami T et al (2003) Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice. Nature 426(6965):454–460
Hata H, Sakaguchi N, Yoshitomi H, Iwakura Y, Sekikawa K et al (2004) Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582–588
Kobayashi K, Suda T, Nan-Ya K, Sakaguchi N, Sakaguchi S et al (2006) Cytokine production profile of splenocytes derived from zymosan A-treated SKG mice developing arthritis. Inflamm Res 55(8):335–341
Sakaguchi S, Sakaguchi N, Yoshitomi H, Hata H, Takahashi T et al (2006) Spontaneous development of autoimmune arthritis due to genetic anomaly of T cell signal transduction: part 1. Semin Immunol 18(4):199–206. doi:10.1016/j.smim.2006.03.007
Caetano-Lopes J, Nery AM, Henriques R, Canhao H, Duarte J et al (2009) Chronic arthritis directly induces quantitative and qualitative bone disturbances leading to compromised biomechanical properties. Clin Exp Rheumatol 27(3):475–482
Yoshitomi H, Sakaguchi N, Kobayashi K, Brown GD, Tagami T et al (2005) A role for fungal {beta}-glucans and their receptor dectin-1 in the induction of autoimmune arthritis in genetically susceptible mice. J Exp Med 201(6):949–960
Das Roy L, Pathangey LB, Tinder TL, Schettini JL, Gruber HE et al (2009) Breast cancer-associated metastasis is significantly increased in a model of autoimmune arthritis. Breast Cancer Res 11(4):R56
Hashimoto M, Hirota K, Yoshitomi H, Maeda S, Teradaira S et al (2010) Complement drives Th17 cell differentiation and triggers autoimmune arthritis. J Exp Med 207(6):1135–1143
Keller KK, Stengaard-Pedersen K, Dagnaes-Hansen F, Nyengaard JR, Sakaguchi S et al (2011) Histological changes in chronic autoimmune SKG-arthritis evaluated by quantitative three-dimensional stereological estimators. Clin Exp Rheumatol 29(3):536–543
Schett G (2007) Cells of the synovium in rheumatoid arthritis. osteoclasts. Arthritis Res Ther 9(1):203
Roux C (2011) Osteoporosis in inflammatory joint diseases. Osteoporos Int 22(2):421–433
Caetano-Lopes J, Nery AM, Canhao H, Duarte J, Cascao R et al (2010) Chronic arthritis leads to disturbances in the bone collagen network. Arthritis Res Ther 12(1):R9
Erben RG (1996) Trabecular and endocortical bone surfaces in the rat: modeling or remodeling? Anat Rec 246(1):39–46
Holmdahl R, Jansson L, Andersson M (1986) Female sex hormones suppress development of collagen-induced arthritis in mice. Arthritis Rheum 29(12):1501–1509
Gerosa M, De Angelis V, Riboldi P, Meroni PL (2008) Rheumatoid arthritis: a female challenge. Womens Health (Lond Engl) 4(2):195–201
Hetland ML, Stengaard-Pedersen K, Junker P, Lottenburger T, Ellingsen T et al (2006) Combination treatment with methotrexate, cyclosporine, and intraarticular betamethasone compared with methotrexate and intraarticular betamethasone in early active rheumatoid arthritis: an investigator-initiated, multicenter, randomized, double-blind, parallel-group, placebo-controlled study. Arthritis Rheum 54(5):1401–1409
Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR et al (1998) Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 93(2):165–176
Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E et al (1999) OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397(6717):315–323
Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS et al (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89(2):309–319
Acknowledgments
The authors are grateful for the technical assistance of Dorthe Clausen, Jette Barlach, and Lotte Arentoft. This work was supported by the Danish Rheumatism Association, the Hørslev Foundation, Clinical Institute Aarhus University, Peter Ryholts Grant, the Hede Nielsens Family Foundation, The A. P. Møller Foundation for the Advancement of Medical Science and Aase and Ejnar Danielsens Foundation.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Keller, K.K., Lindgaard, L.M., Wogensen, L. et al. SKG arthritis as a model for evaluating therapies in rheumatoid arthritis with special focus on bone changes. Rheumatol Int 33, 1127–1133 (2013). https://doi.org/10.1007/s00296-012-2500-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-012-2500-7